Recent Advances in Small Molecule Prodrugs for Cancer Therapy
- Авторы: Wang P.1, Jin X.2, Cai J.3, Chen J.4, Ji M.5
-
Учреждения:
- aff1
- aff2
- aff3
- aff4
- aff5
- Выпуск: Том 14, № 3 (2014)
- Страницы: 418-439
- Раздел: Oncology
- URL: https://kld-journal.fedlab.ru/1871-5206/article/view/695061
- DOI: https://doi.org/10.2174/18715206113139990317
- ID: 695061
Цитировать
Полный текст
Аннотация
Chemotherapy has been performed to treat metastatic cancers but with varying degrees of success. The optimal potential of chemotherapy has not been achieved yet. Numerous compounds cannot be further developed to produce potent drugs because these compounds exhibit poor druggability. To resolve this issue, researchers developed prodrugs in drug discovery because these drugs can be efficiently used. Many small-molecule prodrugs have been designed and synthesized as anticancer agents for several years, and great progress has been achieved. In this study, recently developed, efficient anticancer prodrugs were reviewed, particularly small molecule prodrugs. Moreover, small molecule anticancer prodrugs were summarized according to different types of chemical structures and properties.
Ключевые слова
Об авторах
Peng Wang
aff1
Email: info@benthamscience.net
Xiao Jin
aff2
Email: info@benthamscience.net
Jin Cai
aff3
Email: info@benthamscience.net
Junqing Chen
aff4
Email: info@benthamscience.net
Min Ji
aff5
Email: info@benthamscience.net
Дополнительные файлы
